XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.2
Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Accumulated amortization $ 6,075   $ 6,075   $ 4,050
Advertising and marketing expenses     57,536 $ 55,000  
Research and development costs $ 105,113 $ 147,611 323,789 199,966  
Bad debt expense     0 0  
Amortization expense     $ 2,025 2,025  
Description of patent     straight-line basis over the estimated useful life of 10 years    
Inventory used     $ 1,132 0  
Impaired and written-off     $ 0 $ 0  
Convertible Notes Payable [Member]          
Potential antidilutive shares     1,406,300    
Convertible Notes Payable - Related Parties [Member]          
Potential antidilutive shares     3,552,376    
Restricted Stock Units [Member]          
Potential antidilutive shares     47,665,000 30,915,000